Jane Street’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Jane Street's RPRX Position: Q3 2026 in Review
Jane Street reduced its Royalty Pharma (RPRX) stake by 35% in Q3 2026, selling an estimated $1.09M and leaving 34,986 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #5111.
Jane Street first reported a position in RPRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $191M in Q4 2025. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Jane Street held 34,986 shares of Royalty Pharma worth $2.04M as of Q3 2026.
- Jane Street sold 18,474 Royalty Pharma shares in Q3 2026, an estimated $1.09M.
- Royalty Pharma made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #5111 holding.
- Jane Street first reported a position in Royalty Pharma in Q2 2020 and has held it in 25 quarters since.
- Jane Street's Royalty Pharma position peaked at $191M in Q4 2025.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.